The clinical significance of blood pressure lowering treatment: Is first-line drug choice important? The contrary position

Research output: Contribution to journalArticlepeer-review

Abstract

According to the recommendations of the European Society of Hypertension/European Society of Cardiology guidelines on the diagnosis and management of hypertension, the major benefits of antihypertensive treatment are related to blood pressure reduction per se rather than to the specific drugs used. This article reviews this statement by discussing the evidence provided by a number of clinical trials that blood pressure reduction is more important than the antihypertensive drug choice in uncomplicated hypertensive patients. The difference between drugs will become increasingly important as the cardiovascular risk profile of the patient becomes elevated and/or when associated risk factors or concomitant target organ damage are detected.

Original languageEnglish
Pages (from-to)117-119
Number of pages3
JournalHigh Blood Pressure and Cardiovascular Prevention
Volume15
Issue number3
DOIs
Publication statusPublished - 2008

Keywords

  • Antihypertensive treatment
  • Cardiovascular risk
  • Combination treatment
  • Hypertension guidelines
  • Monotherapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Fingerprint Dive into the research topics of 'The clinical significance of blood pressure lowering treatment: Is first-line drug choice important? The contrary position'. Together they form a unique fingerprint.

Cite this